GenusPlus Group (ASX:GNP) has drawn fresh attention after securing approval to start the North West Transmission Developments Stage 1 project for TasNetworks, alongside releasing full year 2026 earnings and a higher annual dividend.
At a latest share price of A$8.30, GenusPlus Group has eased over the past month and quarter, yet still holds a strong year to date share price return of 33.87% and a very large 5 year total shareholder return. This suggests longer term momentum remains in place even as traders reassess the stock after recent earnings, dividend news and the TasNetworks approval.
Scan beyond GenusPlus Group and review a curated 38 power grid technology and infrastructure stocks that are also exposed to grid upgrades and the long term shift toward more renewable electricity demand.
GenusPlus Group now trades at a clear discount to both analyst targets and one intrinsic value estimate, even after its recent pullback. Is the market correctly pricing in caution, or marking the stock down too far given the latest contract win and results?
Most Popular Narrative: 31.8% Undervalued
The most followed narrative places GenusPlus Group's fair value at A$12.17 per share compared with the last close at A$8.30. That gap rests on some punchy growth and margin assumptions that go well beyond the recent pullback.
GenusPlus is positioned to benefit strongly from Australia's accelerating shift toward renewables and national grid upgrades ("rewiring the nation"), with a record order book and participation in major projects like HumeLink and Clean Energy North, providing enhanced visibility on multi-year revenue growth.
Want to see what is backing that confidence in GenusPlus Group? The narrative focuses on faster top line expansion, higher margins and a future earnings multiple that is expected to reset lower from today. Curious how those pieces are expected to fit together over the next few years? The full narrative sets out the figures that support the A$12.17 fair value.
Result: Fair Value of A$12.17 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, investors still need to weigh risks such as integration challenges from ongoing acquisitions and pressure on margins if large grid projects or government spending plans are delayed.
Find out about the key risks to this GenusPlus Group narrative.
Next Steps
If the optimism in parts of this GenusPlus Group story catches your eye, move quickly and test it against the data for yourself. Then weigh those expectations against the 3 key rewards.
Looking for more GenusPlus Group investment ideas?
Do not stop your research with GenusPlus Group alone. Fresh ideas often appear where you least expect them, and waiting could mean missing the next move.
- Spot potential value early by scanning a 53 elite penny stocks with strong financials that could reward patient investors willing to do the homework.
- Zero in on quality and price together by reviewing a 11 high quality undervalued stocks that combine fundamental strength with appealing valuations.
- Prioritise resilience and capital protection by filtering for a 14 resilient stocks with low risk scores that may offer a smoother ride through market swings.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com